This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Masayoshi Takeda: Innovator in Diabetes Therapeutics
Introduction
Masayoshi Takeda is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of diabetes research, particularly in developing therapeutic agents for type II diabetes. His innovative work has the potential to alleviate insulin resistance, a critical issue in diabetes management.
Latest Patents
Masayoshi Takeda holds 1 patent for a groundbreaking invention titled "Polypeptide - A screening tool and a screening method for a therapeutic agent for type II diabetes." This patent discloses a novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant that are useful in the screening tool and method for identifying effective therapeutic agents.
Career Highlights
Currently, Masayoshi Takeda is associated with Astellas Pharma GmbH, where he continues to advance his research in diabetes therapeutics. His work is instrumental in developing new strategies to combat insulin resistance, which is a major challenge in treating type II diabetes.
Collaborations
Masayoshi Takeda collaborates with notable colleagues, including Noboru Yamaji and Miyuki Katou. Their combined expertise enhances the research efforts at Astellas Pharma GmbH, fostering innovation in the field of diabetes treatment.
Conclusion
Masayoshi Takeda's contributions to diabetes research exemplify the importance of innovation in healthcare. His patented work on polypeptides offers promising avenues for developing effective therapeutic agents for type II diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile